Exelixis Correlations
EXEL Stock | USD 36.58 0.22 0.61% |
The current 90-days correlation between Exelixis and TG Therapeutics is 0.2 (i.e., Modest diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Exelixis moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Exelixis moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
Exelixis Correlation With Market
Average diversification
The correlation between Exelixis and DJI is 0.13 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Exelixis and DJI in the same portfolio, assuming nothing else is changed.
Exelixis |
Moving together with Exelixis Stock
Moving against Exelixis Stock
0.75 | VCYT | Veracyte | PairCorr |
0.72 | VCEL | Vericel Corp Ord | PairCorr |
0.7 | DNLI | Denali Therapeutics | PairCorr |
0.65 | A | Agilent Technologies | PairCorr |
0.61 | ME | 23Andme Holding | PairCorr |
0.58 | VERA | Vera Therapeutics | PairCorr |
0.56 | CDIOW | Cardio Diagnostics | PairCorr |
0.48 | DRTS | Alpha Tau Medical | PairCorr |
0.46 | VANI | Vivani Medical Earnings Call This Week | PairCorr |
0.41 | SABSW | SAB Biotherapeutics | PairCorr |
0.38 | VINC | Vincerx Pharma | PairCorr |
0.38 | VKTX | Viking Therapeutics | PairCorr |
0.37 | VERV | Verve Therapeutics | PairCorr |
0.74 | VRDN | Viridian Therapeutics Downward Rally | PairCorr |
0.68 | ELDN | Eledon Pharmaceuticals Earnings Call This Week | PairCorr |
0.67 | VXRT | Vaxart Inc | PairCorr |
0.63 | VYGR | Voyager Therapeutics | PairCorr |
0.6 | VRPX | Virpax Pharmaceuticals | PairCorr |
0.6 | ELAN | Elanco Animal Health | PairCorr |
0.56 | VTRS | Viatris | PairCorr |
0.51 | DYAI | Dyadic International Earnings Call This Week | PairCorr |
0.51 | VTYX | Ventyx Biosciences | PairCorr |
0.48 | ELEV | Elevation Oncology | PairCorr |
0.47 | VRAX | Virax Biolabs Group | PairCorr |
0.34 | VYNE | Vyne Therapeutics | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Exelixis Stock performing well and Exelixis Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Exelixis' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
TGTX | 2.89 | 0.44 | 0.16 | 0.97 | 2.82 | 7.64 | 18.67 | |||
VKTX | 3.69 | (0.61) | 0.00 | (1.08) | 0.00 | 8.39 | 24.65 | |||
MDGL | 3.02 | 0.29 | 0.07 | 0.16 | 3.99 | 7.64 | 23.14 | |||
BTAI | 8.59 | (0.78) | 0.00 | (0.62) | 0.00 | 22.99 | 101.61 | |||
BMRN | 1.18 | 0.12 | 0.11 | 1.33 | 1.61 | 3.04 | 8.07 | |||
SGEN | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
ALNY | 1.67 | 0.10 | 0.05 | 0.00 | 2.00 | 4.37 | 15.40 | |||
HALO | 1.02 | 0.42 | 0.34 | 0.78 | 0.93 | 2.51 | 7.81 | |||
XFOR | 7.27 | (0.22) | 0.00 | (1.60) | 0.00 | 13.85 | 68.45 | |||
PDSB | 4.61 | (0.48) | 0.00 | (0.63) | 0.00 | 9.21 | 33.91 |
Exelixis Corporate Management
Amy MD | Product VP | Profile | |
Laura Dillard | Executive Resources | Profile | |
Tony Redmond | Senior Resources | Profile | |
Gregg Bernier | VP Marketing | Profile | |
William MD | Senior Affairs | Profile |